Latest news
RevMed, BeOne make clinical trial, Asia deal; MoonLake reports Phase 3 win - Endpoints NewsEndpoints News · Mon, 10 Aug 2026 15:33:00 GMTGreg Verdine’s LifeMine raises $263M for safer immunosuppressant - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 10:30:00 GMTRevolution Medicines preps for pancreatic drug launch, boosting expected 2026 expenses - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 01:31:00 GMTRevolution Medicines Reports Second Quarter 2026 Financial Results and Update on Corporate Progress - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 20:02:00 GMT